nexMPI

WG 3: MNPs as tracer materials

WG 3 Leader: Dr Helena Gavilán

Dr. Helena Gavilán is a Ramón and Cajal Research Fellow at the Universidad Complutense de Madrid (UCM), in the Department of Physical Chemistry. She leads the NanoColloids & Magnetism Lab. Her research focuses on the design, scalable synthesis, and magnetic characterization of magnetic nanoparticles and heterostructured systems for biomedical applications. She obtained her PhD in Chemistry from the Institute of Materials Science of Madrid (ICMM-CSIC), specializing in magnetic nanomaterials based on iron oxides, and subsequently carried out postdoctoral research at internationally leading institutions, including the Italian Institute of Technology (IIT). Dr. Gavilán currently coordinates national and international research projects developing responsive nanomaterials for biomedical applications and serves on the Self-Steering Committee for Future Materials and Technologies, representing UCM within the Una Europa Alliance.

WG 3 Co-leader: Prof Marco Giardiello

Dr.Marco Giardiello is a Senior Lecturer in Chemistry and UKRI Future Leaders Fellow specialising in nanomedicine and medical imaging. He obtained his PhD from the University of Leicester in biological inorganic chemistry (2007), developing responsive MRI contrast agents and lanthanide probes. Following postdoctoral research in Liège and at CEA Grenoble, he joined the University of Liverpool developing HIV nano-therapies, which led to cGMP manufacture for first-in-human trials and co-founding of the spin-out Tandem Nano Ltd. In 2022, he secured the UK’s first MPI Scanner (MomentumTM, Magnetic Insight inc.) through an EPSRC equipment award, thus much of his current research is centred around particle development as MPI tracers and hyperthermia therapy.

WG3:

Our goal is to optimize magnetic properties and surface coating to ensure strong imaging signals while maintaining clinical feasibility.

WG3:

We work on extending nanoparticle functionalities for advanced MPI applications.

WG3:

We study the structure, stability, and magnetism of MPI tracers to improve their biomedical and clinical performance.

WG3:

This working group includes > 100 researchers from 34 countries 

Participant list & How to Join 

WG3:

Our goal is to optimize magnetic properties and surface coating to ensure strong imaging signals while maintaining clinical feasibility.

WG3:

We work on extending nanoparticle functionalities for advanced MPI applications.

WG3:

We study the structure, stability, and magnetism of MPI tracers to improve their biomedical and clinical performance.

WG3:

This working group includes > 100 researchers from 34 countries 

Participant list & How to Join 

Publications

Representative selection. Full list available on ORCID.